Wordt geladen...
New therapeutic strategies for BRAF mutant colorectal cancers
Oncogenic BRAF mutations are found in ~10% of colorectal cancers (CRCs) and predict poor prognosis. Although BRAF inhibitors have demonstrated striking efficacy in BRAF mutant melanomas, BRAF inhibitor monotherapy is ineffective in BRAF mutant CRC. Over the past few years, studies have begun to defi...
Bewaard in:
| Gepubliceerd in: | J Gastrointest Oncol |
|---|---|
| Hoofdauteur: | |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
AME Publishing Company
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4671849/ https://ncbi.nlm.nih.gov/pubmed/26697198 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2078-6891.2015.076 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|